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A case–control study was performed to assess the potential influence of CYP19 Arg
264Cys and CYP1B1 Leu
432Val polymorphisms on
breast cancer risk in a series of Korean breast cancer patients and controls. The results suggest that the CYP19 Arg
264Cys
polymorphism modifies breast cancer risk (OR¼1.5, 95% CI¼1.1–2.2), especially in association with alcohol consumption (P for
interaction¼0.04), whereas the CYP1B1 Leu
432Val polymorphism appears to play no role here.
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Breast cancer is the second most frequent cancer in Korean women
and its incidence is increasing (Yoo et al, 1998). Lifetime
cumulative exposure to oestrogens is known as the most important
risk factor for breast cancer (Yager, 2000). A variety of different
enzymes are involved in the synthesis of oestrogen from
cholesterol and further metabolism of oestrogen (Thompsen and
Ambrosone, 2000). Polymorphisms of genes encoding for these
proteins are regarded as the candidates for elevated breast cancer
risk.
The CYP19 gene encodes aromatase, which catalyses the
formation of oestrogens from testosterone and androstenedione.
To date, several polymorphisms have been found in the CYP19
gene (i.e. Polymeropulous et al, 1991; Sourdaine et al, 1994;
Siegelmann-Danieli and Buetow, 1999; Healey et al, 2000; Miyoshi
et al, 2000). One of these, a C-to-T variation in exon 7 resulting in
an Arg
264Cys amino-acid exchange, has been shown to be very
common in Asians (Watanabe et al, 1997; Miyoshi et al, 2000) and
could thus be an important modifier of breast cancer risk in this
ethnic group.
The CYP1B1 enzyme is known to be involved in the formation of
4-hydroxyoestradiol, which is a catechol metabolite of oestrogen
(Hayes et al, 1996). A C-to-G variation in exon 3 of the CYP1B1
gene results in a Leu
432Val amino-acid exchange. The Leu/Leu
genotype has been associated with increased breast cancer risk in
an Asian population (Zheng et al, 2000) but controversial results
have been reported as well (Bailey et al, 1998; Watanabe et al,
2000).
In this study, we have evaluated the potential influence of CYP19
Arg
264Cys and CYP1B1 Leu
432Val polymorphisms on the breast
cancer risk among Korean women as an extension of our previous
work in this study population (Park et al, 2000; Yim et al, 2001).
MATERIALS AND METHODS
Study subjects
The criteria of subject selection and details of data collection on
lifestyle have been described elsewhere (Park et al, 2000; Yim et al,
2001). Eligible study population consisted of 389 incident breast
cancer cases and 346 controls with no other known cancer or
systemic disease, admitted in 1995–2001 to three teaching
hospitals located in Seoul, Korea (Seoul National University
Hospital, Borame Hospital, and Asan Medical Center). Each
patient was frequency-matched to one control in the following
age groups: under 30, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59,
60–69, and over 70 years; 288 cases and 288 controls were selected
and genotyped for CYP19. Informed consents were obtained at the
time of blood withdrawal. Information on demographic character-
istics, education, marital status, reproductive factors and men-
struation, family history of breast cancer in the first and second
relatives, lifestyle habits (including smoking, alcohol drinking, and
diet) was collected using a questionnaire administered by trained
interviewers.
Genotyping
DNA was isolated using standard methods from blood drawn into
10ml heparinised tubes and stored at  701C until use. The CYP19
genotypes were determined by dynamic allele-specific hybridisa-
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ytion system (DASH, Hybaid). Briefly, a 63bp long amplification
product was obtained using about 10ng DNA as template in a
polymerase chain reaction (PCR) with 20pmol of oligonucleotide
primer P1 (50-TGC CAT AGA AGT TCT GAT AGC-30) and 4pmol
of primer P2 (biotin-labelled 50-TCT TCC AGT TTC TCT TCT GT-
30) (Bioneer: Seoul, Korea) in a total volume of 20ml. The
amplification conditions were: initial denaturation at 951C for
5min followed by 45 cycles of 15s at 941C and 30s at 581C
(Multiblock System, Hybaid). The PCR products were hybridised
with the following probes: 50-AAA AAA GAC GCA GGA TT-30 and
50-AAA AAA GAT GCA GGA TT-30. The CYP1B1 was genotyped
for 241 cases and 290 controls recruited from 1995 to 1999 by a
real-time PCR-based method as described by Bru ¨ning et al (1999).
Statistical analyses
Odds ratios (ORs) and 95% confidence intervals (CIs) were
estimated by unconditional logistic regression analysis adjusting
for age, education, body-mass index, age at first full-term
pregnancy, family history of breast cancer, duration of breast
feeding, and alcohol consumption. Information on alcohol
consumption was collected by three questions: (1) How frequently
do you drink alcohol (i.e., per week, month, year)? (2) How long
have you been drinking? (3) Have you ever quitted drinking?
Alcohol intake was categorised as: never-drinking (never and less
than once per month) or ever drinking (at least once per month).
Interactions between known risk factors (alcohol consumption and
age at first full-term pregnancy) and each genotype were evaluated
by likelihood ratio test. The difference of two  2logL values of
logistic models with and without interaction terms was referred to
tables of w
2 on one degree of freedom.
RESULTS
The distribution of established breast cancer risk factors was
compared in cases and controls (Table 1). These two groups
differed statistically significantly in education (OR¼2.1, 95%
CI¼1.5–3.0), age at first full-term pregnancy (OR¼1.8, 95%
CI¼1.1–2.9), family history of breast cancer in first and
second degree relatives (OR¼2.6, 95% CI¼1.2–5.6), and
alcohol consumption (OR¼1.5, 95% CI¼1.0–2.2). The dis-
tributions of CYP19 and CYP1B1 genotypes are shown in
Table 2. The genotype distributions in the control subjects
agreed with those predicted by the Hardy–Weinberg equilibrium.
The frequency of CYP19 Cys allele-containing genotypes (39%)
was somewhat lower than that previously found in Japanese
women (52–54%) (Watanabe et al, 1997; Miyoshi et al, 2000),
whereas the frequency of CYP19 Cys allele-containing
genotypes was very low, less than 10% for Caucasians
(Siegelmann-Danieli and Buetow, 1999; Healey et al, 2000). The
frequency of CYP1B1 Val allele-containing genotype (21%), on the
other hand, was similar to that (29%) found in Japanese women
(Watanabe et al, 2000). However, it was rather surprisingly lower
than that found in Chinese women (85%) (Zheng et al, 2000),
Caucasians (70–81%), and African Americans (95%) (Bailey et al,
1998; Ko et al, 2001).
The CYP19 Cys allele-containing genotypes showed a signifi-
cantly increased risk of breast cancer (OR¼1.5, 95% CI¼1.1–
2.2), whereas the CYP1B1 Val allele-containing genotypes had no
effect in this context (OR¼1.0, 95% CI¼0.7–1.6) (Table 2).
When the genotype effects were evaluated in relation with the
known risk factors for breast cancer (alcohol consumption, age at
first full-term pregnancy), a significant interactive effect was
observed between CYP19 genotype and alcohol consumption (P for
interaction¼0.044). Ever-drinking women with CYP19 Cys allele-
containing genotypes showed a 3.3-fold risk (95% CI¼1.7–6.5)
for breast cancer compared with never-drinking women with the
Arg/Arg genotype (Table 3).
In contrast to the CYP19 genotypes, no interaction was observed
between the known risk factors for breast cancer and the CYP1B1
genotypes. Neither was there a gene–gene interaction between the
CYP19 and CYP1B1 genotypes.
Table 1 Selected characteristics for matched breast cancer cases and control subjects
Cases Controls OR
N (%) N (%) (95% CI)
a
Age
p39 79 (27.4) 79 (27.4)
40–49 90 (31.3) 90 (31.3)
50–59 74 (25.7) 74 (25.7)
X60 45 (15.6) 45 (15.6)
Education
Under high school 154 (54.2) 204 (71.6) 1.0
At and over high school 130 (45.8) 81 (28.4) 2.1 (1.5–3.0)
Age at first full-term pregnancy (FFTP)
FFTPo30 242 (84.0) 259 (90.2) 1.0
Nulliparous or FFTPX30 46 (16.0) 28 (9.8) 1.8 (1.1–2.9)
Family history of breast cancer in first and second degree relatives
No 263 (91.3) 278 (96.5) 1.0
Yes 25 (8.7) 10 (3.5) 2.6 (1.2–5.6)
Alcohol consumption
o1/month 208 (72.2) 229 (79.5) 1.0
X1/month 80 (27.8) 59 (20.5) 1.5 (1.0–2.2)
Cigarette smoking
o400 cigarettes/lifetime 270 (93.8) 271 (94.1) 1.0
X400 cigarettes/lifetime 18 (6.3) 17 (5.9) 1.1 (0.5–2.1)
aORs were not adjusted for other covariates.
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Our results suggest that both CYP19 genotype and alcohol
consumption play important roles in breast cancer development,
and that these factors could synergistically increase the risk of
breast cancer in Korean women. The contrasting findings with
previous studies (Watanabe et al, 1997; Siegelmann-Danieli and
Buetow, 1999; Healey et al, 2000; Miyoshi et al, 2000) may be
because of the differences in subject selection (noncomparable
controls in the above studies), sample size (less than 200 in both
cases and controls), and inadequate statistical power, marked
differences in frequency of Cys allele (52–54% for Japanese
women, 39% for Korean women, and less than 10% for Caucasian),
and different genotyping methods (single-strand conformation
polymorphism, sequencing, and dynamic allele-specific hybridisa-
tion).
The Arg
264Cys polymorphism is located in or near recognition
site of CYP19 aromatase and thus, it might enhance the oestrogen
synthesis and exposure to endogenous oestrogen. However,
it is also be possible that CYP19 Arg
264Cys polymorphism is in
linkage disequilibrium with other important polymorphic
site such as TTTA repeat polymorphism (Kristensen et al, 1998;
Haiman et al, 2000; Baxter et al, 2001). Watanabe et al (1997)
reported, however, that Arg
264Cys genotype did not affect
the aromatase activity in vitro test so further studies on the
potential role of this polymorphism in breast cancer aetiology are
required.
One mechanism by which alcohol consumption may increase
breast cancer risk is through increased circulating oestrogen and
androgen levels (Singletary and Gapstur, 2001). In a controlled
feeding study, serum levels of estrone sulphate and dehydroepian-
drosterone sulphate were significantly increased by the consump-
tion of 30g of alcohol per day in postmenopausal women (Dorgan
et al, 2001). Since CYP19 is also involved in the biosynthesis of
oestrogen, the CYP19 genotype and alcohol consumption may
synergistically increase breast cancer risk by affecting both
synthesis and metabolism of oestrogen.
In contrast to the CYP19 genotype, we found no association
between CYP1B1 genotype and breast cancer. While our finding is
consistent with some previous studies (Bailey et al, 1998;
Watanabe et al, 2000), Zheng et al (2000) reported that Chinese
women with Leu/Leu genotype had a 2.3-fold elevated risk of
breast cancer among 186 cases and 200 controls. This incon-
sistency might at least partly be explained by the remarkable
difference in the frequency of Val allele-containing genotypes (21
vs 85%).
In conclusion, the results of this study support the hypo-
thesis that CYP19 genotype and alcohol consumption play
important roles in breast cancer development and that these
factors may synergistically increase the risk of this malignancy
in Korean women. Epidemiological studies with large sample
sizes are, however, required to confirm these preliminary
findings and to evaluate the role of the other CYP19 genotypes
of potential interest in breast cancer development in this ethnic
group.
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